Market
Scenario:
Glaucoma
is a disease characterized by fluid builds up in the front part of your eye
which results in damages to the eye’s optic nerve which may lead to blindness
if left untreated. Open angle glaucoma (OAG) is the most common type of
glaucoma followed by closed angle glaucoma (CAG) and these two account for
greater than 50% of glaucoma cases. According to World Health Organization
(WHO) estimates, Glaucoma is the second most common cause of blindness
worldwide after cataract.
The market for glaucoma is increasing at an
impressive rate primarily driven by the growing number of geriatrics. Older
population has higher risk of developing glaucoma although other age groups may
be affected. Other high risk groups include diabetics and those with a family
history of glaucoma. The other market driving factors are increasing awareness,
growing healthcare expenditure and screening etc.
The
product development strategies have been very impressive with the surgery
option. The last decade has seen impressive additions to the surgery options
such as laser therapy, photodynamic therapy etc. The market constraints are
excellent efficacy and efficiency of present drugs especially prostaglandin
analogs and carbonic anhydrase inhibitors, which has set the bar for a new
therapy extremely high and the loss of patent protection on the major drugs
used to treat glaucoma.
Taking all factors into consideration, we expect
the Asia Pacific glaucoma treatment market to reach around $ 888.94 million in
2023 from $576.0 million in 2017, by the end of the forecast period at a CAGR
of ~ 7.5 %. While the glaucoma drug market will grow by a flat CAGR of 2.1% the
glaucoma surgery market is poised for an explosive CAGR of 18.5 %.
Key
Players for Asia-Pacific Glaucoma Treatment Market:
Some of
the key players in this market are: Novartis AG, Pfizer Inc., Allergan, Merck
& Co., Ocular Therapeutix Inc, pSivida Corp, Icon Bioscience Inc, Amorphex
Therapeutics LLC., Ellex, Quantel, Lumenis, and Lightmed among others.
Segments:
Asia-Pacific
Glaucoma Treatment Market has been segmented on the basis of disease indication
which comprises Closed Angle Glaucoma (CAG), open angle glaucoma (OAG),
secondary glaucoma, congenital glaucoma and other. On the basis of drug class;
market is segmented into prostaglandin analogs (PGAS), alpha agonist, beta
blockers, cholinergic drugs, carbonic anhydrase inhibitors, and others. On the
basis of surgery; market is segmented into laser iridotomy, laser
trabeculoplasty, aqueous shunt surgery and peripheral iridectomy. On the basis
of end users; market is segmented into hospitals and home users.
Regional
Analysis of Asia-Pacific Glaucoma Treatment Market:
The
healthcare sector of Asia Pacific varies immensely by countries. However the
Asia Pacific region has lower public sector expenditure and most treatments
involve out of pocket expenditure. Further the eye care has been a neglected
segment especially in the poor countries of Asia Pacific region. Japan and
South Korea are the leading markets while China will be the fastest growing due
to rising healthcare expenditure and faster economic growth. Also the presence
of strong generics especially in nations like India will lead to volume growth
of anti-glaucoma drugs. The surgery market however will see fastest growth in
Japan as compared to developing parts of Asia Pacific.
Detailed Table
of Contents:
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
List Of Tables
Table 1 Asia-Pacific Glaucoma Treatment Market, 2013-2022 (Usd
Million)
Table 2 Asia-Pacific Glaucoma Treatment Market, By Disease
Indication, 2013-2022 (Usd Million)
Table 3 Asia-Pacific Glaucoma Treatment Market, By Drug Class,
2013-2022 (Usd Million)
Table 4 Asia-Pacific Glaucoma Treatment Market, By Surgery,
2013-2022 (Usd Million)
Table 5 Asia-Pacific Glaucoma Treatment Market, By End Users,
2013-2022 (Usd Million)
Table 6 Asia-Pacific Glaucoma Treatment Market, By Region,
2013-2022 (Usd Million)
List Of Figures
Figure
1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 Asia-Pacific Glaucoma Treatment Market, By Disease
Indication
Figure 4 Asia-Pacific Glaucoma Treatment Market, By Drug Class
Figure 5 Asia-Pacific Glaucoma Treatment Market, By Surgery
Figure 6 Asia-Pacific Glaucoma Treatment Market, By End Users
Figure 7 Asia-Pacific Glaucoma Treatment Market, By Region
Figure 8 Asia-Pacific Glaucoma Treatment Market: Company Share
Analysis, 2015 (%)
...Continued
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
